A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for Plasma Cell Myeloma Refractory
Sites in St Louis, Kansas City +32 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06356571·Phase 2·Recruiting·Listed Apr 2024